GlassScriptPhysician profile
Amy J Weaver
NPI 1891715025
$4,029.20
in general payments reported to CMS, 2019-2025
44 companies · $779 in 2025
The $779 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $614 · 2022: $734 · 2023: $1,227 · 2024: $674 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $741.88 | 2021-2025 | |
| Indivior INC. | $284.75 | 2022-2024 | Sublocade |
| Lilly USA, LLC | $255.05 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $247.95 | 2021-2022 | |
| Novo Nordisk INC | $245.15 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $232.92 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $175.77 | 2021-2024 | |
| Abbott Laboratories | $174.48 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $154.83 | 2021-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $143.60 | 2021-2025 | |
| Exact Sciences Corporation | $137.55 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.38 | 2022-2025 | Xifaxan |
| Echosens North America, INC. | $80.29 | 2025 | Fibroscan |
| Edwards Lifesciences Corporation | $78.73 | 2022-2025 | Hemosphere, Sapien 3 Ultra Resilia |
| Abiomed | $74.53 | 2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $65.98 | 2023 | Inspire |
| Baxter Healthcare | $62.74 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Mylan Specialty L.P. | $61.31 | 2024 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $51.72 | 2022 | |
| Endogastric Solutions, INC | $51.00 | 2024 | Esophyx |
| Shield Therapeutics INC | $49.16 | 2023-2024 | Accrufer |
| Organon LLC | $38.26 | 2023 | Nexplanon |
| Noven Therapeutics, LLC | $36.85 | 2023 | Xelstrym, Secuado |
| Otsuka America Pharmaceutical, INC. | $35.52 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $35.35 | 2021 | |
| Viatris Specialty LLC | $34.20 | 2025 | Yupelri |
| Teleflex LLC | $33.05 | 2025 | Turnpike |
| Sumitomo Pharma America, INC. | $30.89 | 2023-2024 | Gemtesa |
| Medtronic, INC. | $30.12 | 2023-2025 | Intellis Adaptivestim, Venaseal |
| Sunovion Pharmaceuticals INC. | $29.92 | 2022 | |
| Amgen INC. | $25.47 | 2022-2025 | Repatha |
| Organogenesis INC. | $24.94 | 2022 | |
| Daiichi Sankyo INC. | $24.44 | 2022 | |
| Dynavax Technologies Corporation | $22.39 | 2025 | Heplisav-B |
| Boston Scientific Corporation | $19.14 | 2024 | |
| Corcept Therapeutics | $19.06 | 2025 | Korlym |
| Axsome Therapeutics, INC. | $16.79 | 2024 | Auvelity |
| Currax Pharmaceuticals LLC | $15.78 | 2025 | Contrave |
| Allergan, INC. | $15.14 | 2022 | |
| Ethicon US, LLC | $15.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.86 | 2025 | Zoryve |
| Idorsia Pharmaceuticals US INC | $14.59 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $14.35 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.